Actelion

Drug Product Facility From Molecule to Medicine Martine Clozel, Research in the Pharmaceutical Industry Actelion To Appeal Jury Verdict In Asahi Kasei Litigation ZURICH -(Dow Jones)- Europe’s largest biotech Actelion Ltd (ATLN.VX) Wednesday said it will appeal against the final U.S. jury verdict that awarded Asahi Kasei Pharma Corp. (AHKSY) compensatory damages of up to $547 million and punitive … BB Biotech backs Actelion in battle with Elliott (Reuters) | WorldNews ZURICH (Reuters) – Biotech investment fund BB Biotech has come out in support of Actelion Ltd, giving the Swiss biotech group crucial backing in its spat with. Hold the Presses!: Actelion Pharmaceuticals Ltd (CH) – Actelion to … ALLSCHWIL/BASEL, SWITZERLAND – 04 May 2011 – Actelion (SIX: ATLN) today commented on the verdict issued in regard to Asahi Kasei Pharma Corp. v. Actelion Ltd. et al. (case number CIV 478533, Superior Court of the State of California, … Actelion Dismisses Investor Criticism Ahead Of AGM | Management Actelion Dismisses Investor Criticism Ahead Of AGM ZURICH -(Dow Jones)- Actelion Ltd (ATLN.VX) Monday dismissed criticism from investor Elliott Advisors, who bashed the Swiss firm’s management for having lost a legal battle that could … BIO Technology News – Actelion to appeal US compensation ruling to … Swiss biotechnology group Actelion said Wednesday that it would appeal against $547 million (370 million euros) in damages awarded by a California court to Japanese company Asahi Kasei Pharma. Actelin said in a statement that it had … PharmaTimes says: PT News: Actelion defends actions as lawsuit is lost in USA http://dlvr.it/QZ2Hq #pharmaceuticals

Posted by on May 4, 2011. Filed under News. You can follow any responses to this entry through the RSS 2.0. You can skip to the end and leave a response. Pinging is currently not allowed.